Article Versions Notes

Kyrkou SG, Bistas V-P, Salvanou E-A, Crook T, Giannakopoulou M, Zoi V, Leonardos M, Fotopoulos A, Sioka C, Leonardos I, et al. Development of AGT-7: An Innovative ^99mTc-Labeled Theranostic Platform for Glioblastoma Imaging and Therapy. Pharmaceuticals. 2025; 18(8):1175. https://doi.org/10.3390/ph18081175

Kyrkou, Stavroula G., Vasileios-Panagiotis Bistas, Evangelia-Alexandra Salvanou, Timothy Crook, Maria Giannakopoulou, Vasiliki Zoi, Maximos Leonardos, Andreas Fotopoulos, Chrissa Sioka, Ioannis Leonardos, and et al. 2025. "Development of AGT-7: An Innovative ^99mTc-Labeled Theranostic Platform for Glioblastoma Imaging and Therapy" Pharmaceuticals 18, no. 8: 1175. https://doi.org/10.3390/ph18081175

Kyrkou, S. G., Bistas, V.-P., Salvanou, E.-A., Crook, T., Giannakopoulou, M., Zoi, V., Leonardos, M., Fotopoulos, A., Sioka, C., Leonardos, I., Alexiou, G. A., Bouziotis, P., & Tzakos, A. G. (2025). Development of AGT-7: An Innovative ^99mTc-Labeled Theranostic Platform for Glioblastoma Imaging and Therapy. Pharmaceuticals, 18(8), 1175. https://doi.org/10.3390/ph18081175